Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Regulation

How FDA could learn from oncology

Office of Oncology Director Richard Pazdur believes his experience can be applied to other therapeutic areas

By Steve Usdin, Washington Editor
October 30, 2024 9:48 PM UTC

Over the last two decades, scientific discoveries have propelled a surge in cancer drug development, but progress in bringing new medicines to patients has also relied on a less obvious factor. Innovative regulatory policies have been essential.

No one has had a greater influence over cancer drug regulation in the modern era than Richard Pazdur, director of FDA’s Oncology Center of Excellence. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

U.S. Food and Drug Administration (FDA)